4CPS-151 Optimisation programme of biological therapies in rheumatoid arthritis: results of create registry after 3 years

BACKGROUND: Dose optimisation (dose reduction or dose spacing) is a therapeutic strategy applied in patients with rheumatoid arthritis (RA) who have managed to maintain clinical remission. This strategy reduces the frequency of adverse effects and promotes cost savings. PURPOSE: Evaluate effectivene...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Ruiz, S de la Fuente, Ugalde, P Font, Aranzana, M Cárdenas, Villegas, MC Castro, Gómez, M Romero, Castro, R Ortega, Guitiérrez, J Calvo, Vílchez, D Ruiz, Estévez, E Colllantes
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 4: Clinical pharmacy services
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.242
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars